When was SHL founded?

SHL was founded in 1989 and raised its 1st funding round 31 years after it was founded.

Where is SHL located?

SHL is headquartered in Zug, Switzerland. It is registered at Deerfield Beach, Florida.

How many employees does SHL have?

As of Jul 31, 2026, the latest employee count at SHL is 2191.

Is SHL a funded company?

SHL is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on Jan 03, 2020.

When was the latest funding round of SHL?

SHL's latest funding was a $***** Unattributed round on Dec 09, 2022, with participation from 2 investors. Its primary sector is Drug Delivery. In Switzerland, the Drug Delivery sector has seen $100M in funding in 2026 to date.

Where does SHL rank among its competitors?

SHL ranks 4th amongst 33 active competitors, of which 7 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Pirouette Pharma, which secured $1.08M in Mar, 2026.

Who are the top competitors of SHL?

SHL's top competitors include Crossject, Xeris Pharmaceuticals and Windgap Medical. Among them, Pirouette Pharma secured the most recent funding round in March, 2026.

SHL - 2026 Company Profile, Funding & Competitors

Company Details

Developer and manufacturer of autoinjectors and drug delivery system solutions. The business specializes in the design, development, and production of medical devices for pharmaceutical and biotechnology industries. It offers a range of autoinjectors, pen injectors, and electromechanical delivery systems. Services include feasibility studies, device design, process engineering, and large-scale manufacturing. Through a vertically integrated model, the company supports the development of combination products across various therapeutic areas, providing automation solutions and secondary packaging support. Operations span design, testing, assembly, and supply chain management to facilitate drug delivery for clinical and commercial applications.

Website: www.shl-medical.com/
Social
Email ID: *****@shl-medical.com
Phone Number: +41 **********
Registered Address: Deerfield Beach, Florida

Key Metrics

Founded Year

1989

Location

Zug, Switzerland

Stage

Funding Raised

Latest Funding Round

Unattributed, Dec 09, 2022, $*****

Investors

EQT & 1 more

Ranked

4^th among 33 active competitors

Employee Count

2,191 as on Jul 31, 2026

Investment & Acquisitions

Superior Tooling & 1 more

Similar Companies

Crossject & 32 more

View SHL's full profile

SHL is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Shl Medical Ag CIN: 1332440 , Switzerland, Active	May 13, 2024	-	-	-
SHL PHARMA LLC CIN: 273069241 , United States, Active	Dec 31, 1999	-	414 (As on Dec 31, 2024)	-

SHL has raised funding over 2 rounds. Its first funding round was on Jan 03, 2020. Its latest funding round was a Unattributed round on Dec 09, 2022 for $*****. 2 investors participated in its latest round. SHL has 2 institutional investors.

Here is the list of recent funding rounds of SHL:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 09, 2022	1255289	Unattributed	1789204	8240066	8046134	6525819
Jan 03, 2020	4100639	Unattributed	5244691	5157708	3807489	EQT

Access funding benchmarks and valuations. Sign up today!

View details of SHL's funding rounds and investors

SHL's employee count trend

SHL has 2,191 employees as of Jul 26. Here is SHL's employee count trend over the years:

Uncover SHL's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SHL include Crossject, Xeris Pharmaceuticals and Windgap Medical. Here is the list of Top 10 competitors of SHL, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Crossject 2001, Dijon (France), Public	Needle-free self-injectable drugs	$40.3M	Rothschild & Co, GSK & 5 others	60/100
2nd	Xeris Pharmaceuticals 2005, Chicago (United States), Public	Developer of liquid-stable injectables for the delivery of drugs	$155M	Redmile Group, Central Texas Angel Network ... & 19 others	60/100
3rd	Windgap Medical 2011, Boston (United States), Series B	Provider of drug delivery autoinjector for the treatment of anaphylaxis	$76.7M	Taiwania Capital, SKK & 12 others	44/100
4th	SHL 1989, Zug (Switzerland), Funding Raised	Developer and manufacturer of autoinjectors and drug delivery system solutions	-	EQT, Athos Capital	44/100
5th	Eveon 2009, Montbonnot Saint Martin (France), Seed	Manufacture of connected medical devices focused on the preparation and administration of therapeutic treatment	$4.05M	MEDEVICE, Credit Agricole Alpes Developpement ... & 1 others	42/100
6th	MIT 1978, Montreal (Canada), Public	Provider of needleless injectors for various medical applications	-	-	36/100
7th	Qlibrium 2014, Woburn (United States), Funding Raised	Provider of on‑body drug delivery systems	-	JLABS, MassChallenge & 1 others	36/100
8th	Cellular Vehicles 2021, San Mateo (United States), Funding Raised	Developer of process automation tools for cell-based therapy manufacturing	-	Boost VC, HHS	34/100
9th	Asan Therapeutics Boston (United States), Unfunded	Developer of drug delivery technology to treat cancer patients	-	-	32/100
10th	Pirouette Pharma 2021, Portsmouth (United States), Seed	Developer of auto-injector technology for injectable medicines and partner programs	$3.43M	HHS, Founders	31/100